Avantel Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 7:48 pm

Quick Insight

Avantel Ltd's current market dynamics present an intriguing narrative for investors in the telecom equipment sector, with a share price of 148 and a market capitalization of 3,924 Cr., reflecting a P/E ratio of 69.5. The company's robust financial performance is underscored by a commendable ROE of 28.6% and ROCE of 37.0%, while maintaining a healthy OPM of 21.89%. Additionally, with reserves standing at 199 Cr. and minimal borrowings of ₹26 Cr., Avantel appears to have a strong financial foundation. However, investors should note the high P/BV ratio of 11.70x and a relatively extended CCC of 439 days, suggesting potential liquidity and valuation concerns that warrant further investigation.

Competitors of Avantel Ltd

All Competitor Stocks of Avantel Ltd

Quarterly Result

Last Updated: August 1, 2025, 6:55 am

Below is a detailed analysis of the quarterly data for Avantel Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 51.84 Cr.. The value appears strong and on an upward trend. It has increased from 49.14 Cr. (Mar 2025) to 51.84 Cr., marking an increase of 2.70 Cr..
• For Expenses, as of Jun 2025, the value is 40.49 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.59 Cr. (Mar 2025) to 40.49 Cr., marking an increase of 3.90 Cr..
• For Operating Profit, as of Jun 2025, the value is 11.35 Cr.. The value appears to be declining and may need further review. It has decreased from 12.55 Cr. (Mar 2025) to 11.35 Cr., marking a decrease of 1.20 Cr..
• For OPM %, as of Jun 2025, the value is 21.89%. The value appears to be declining and may need further review. It has decreased from 25.54% (Mar 2025) to 21.89%, marking a decrease of 3.65%.
• For Other Income, as of Jun 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.48 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.43 Cr..
• For Interest, as of Jun 2025, the value is 0.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.66 Cr. (Mar 2025) to 0.80 Cr., marking an increase of 0.14 Cr..
• For Depreciation, as of Jun 2025, the value is 3.90 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.80 Cr. (Mar 2025) to 3.90 Cr., marking an increase of 1.10 Cr..
• For Profit before tax, as of Jun 2025, the value is 6.70 Cr.. The value appears to be declining and may need further review. It has decreased from 9.57 Cr. (Mar 2025) to 6.70 Cr., marking a decrease of 2.87 Cr..
• For Tax %, as of Jun 2025, the value is 31.04%. The value appears to be increasing, which may not be favorable. It has increased from 23.09% (Mar 2025) to 31.04%, marking an increase of 7.95%.
• For Net Profit, as of Jun 2025, the value is 4.62 Cr.. The value appears to be declining and may need further review. It has decreased from 7.36 Cr. (Mar 2025) to 4.62 Cr., marking a decrease of 2.74 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.17. The value appears to be declining and may need further review. It has decreased from 0.28 (Mar 2025) to 0.17, marking a decrease of 0.11.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:28 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:47 pm

Below is a detailed analysis of the balance sheet data for Avantel Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 49.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 49.00 Cr..
• For Reserves, as of Mar 2025, the value is 199.00 Cr.. The value appears strong and on an upward trend. It has increased from 123.00 Cr. (Mar 2024) to 199.00 Cr., marking an increase of 76.00 Cr..
• For Borrowings, as of Mar 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 18.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 8.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 23.00 Cr.. The value appears to be improving (decreasing). It has decreased from 34.00 Cr. (Mar 2024) to 23.00 Cr., marking a decrease of 11.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 298.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 223.00 Cr. (Mar 2024) to 298.00 Cr., marking an increase of 75.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 95.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2024) to 95.00 Cr., marking an increase of 51.00 Cr..
• For CWIP, as of Mar 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Mar 2024) to 5.00 Cr., marking a decrease of 11.00 Cr..
• For Investments, as of Mar 2025, the value is 30.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 30.00 Cr., marking an increase of 13.00 Cr..
• For Other Assets, as of Mar 2025, the value is 168.00 Cr.. The value appears strong and on an upward trend. It has increased from 146.00 Cr. (Mar 2024) to 168.00 Cr., marking an increase of 22.00 Cr..
• For Total Assets, as of Mar 2025, the value is 298.00 Cr.. The value appears strong and on an upward trend. It has increased from 223.00 Cr. (Mar 2024) to 298.00 Cr., marking an increase of 75.00 Cr..

Notably, the Reserves (199.00 Cr.) exceed the Borrowings (26.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Avantel Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.32. This value is below the healthy minimum of 5. It has increased from 2.16 (Mar 24) to 2.32, marking an increase of 0.16.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.30. This value is below the healthy minimum of 5. It has increased from 2.14 (Mar 24) to 2.30, marking an increase of 0.16.
• For Cash EPS (Rs.), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 3. It has increased from 2.47 (Mar 24) to 2.79, marking an increase of 0.32.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.69. It has increased from 6.75 (Mar 24) to 9.69, marking an increase of 2.94.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.69. It has increased from 6.75 (Mar 24) to 9.69, marking an increase of 2.94.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 10.18. It has increased from 9.22 (Mar 24) to 10.18, marking an increase of 0.96.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 3.85. This value is within the healthy range. It has increased from 3.42 (Mar 24) to 3.85, marking an increase of 0.43.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.37. This value is within the healthy range. It has increased from 3.11 (Mar 24) to 3.37, marking an increase of 0.26.
• For PBT / Share (Rs.), as of Mar 25, the value is 3.25. This value is within the healthy range. It has increased from 2.94 (Mar 24) to 3.25, marking an increase of 0.31.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 2.16 (Mar 24) to 2.31, marking an increase of 0.15.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 2.16 (Mar 24) to 2.31, marking an increase of 0.15.
• For PBDIT Margin (%), as of Mar 25, the value is 37.84. This value is within the healthy range. It has increased from 37.09 (Mar 24) to 37.84, marking an increase of 0.75.
• For PBIT Margin (%), as of Mar 25, the value is 33.11. This value exceeds the healthy maximum of 20. It has decreased from 33.74 (Mar 24) to 33.11, marking a decrease of 0.63.
• For PBT Margin (%), as of Mar 25, the value is 31.88. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 31.88.
• For Net Profit Margin (%), as of Mar 25, the value is 22.65. This value exceeds the healthy maximum of 10. It has decreased from 23.42 (Mar 24) to 22.65, marking a decrease of 0.77.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 22.65. This value exceeds the healthy maximum of 20. It has decreased from 23.42 (Mar 24) to 22.65, marking a decrease of 0.77.
• For Return on Networth / Equity (%), as of Mar 25, the value is 23.79. This value is within the healthy range. It has decreased from 32.02 (Mar 24) to 23.79, marking a decrease of 8.23.
• For Return on Capital Employeed (%), as of Mar 25, the value is 32.29. This value is within the healthy range. It has decreased from 44.35 (Mar 24) to 32.29, marking a decrease of 12.06.
• For Return On Assets (%), as of Mar 25, the value is 19.46. This value is within the healthy range. It has decreased from 24.34 (Mar 24) to 19.46, marking a decrease of 4.88.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.05, marking an increase of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. It has increased from 0.07 (Mar 24) to 0.08, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.23 (Mar 24) to 0.98, marking a decrease of 0.25.
• For Current Ratio (X), as of Mar 25, the value is 4.84. This value exceeds the healthy maximum of 3. It has increased from 3.24 (Mar 24) to 4.84, marking an increase of 1.60.
• For Quick Ratio (X), as of Mar 25, the value is 3.09. This value exceeds the healthy maximum of 2. It has increased from 2.22 (Mar 24) to 3.09, marking an increase of 0.87.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.57. This value is below the healthy minimum of 4. It has decreased from 1.72 (Mar 24) to 1.57, marking a decrease of 0.15.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.08 (Mar 24) to 0.00, marking a decrease of 3.08.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.70 (Mar 24) to 0.00, marking a decrease of 2.70.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.92 (Mar 24) to 0.00, marking a decrease of 96.92.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.30 (Mar 24) to 0.00, marking a decrease of 97.30.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 30.96. This value is within the healthy range. It has increased from 19.92 (Mar 24) to 30.96, marking an increase of 11.04.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 19.53. This value is within the healthy range. It has increased from 13.58 (Mar 24) to 19.53, marking an increase of 5.95.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,788.68. It has increased from 2,406.62 (Mar 24) to 2,788.68, marking an increase of 382.06.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 11.19. This value exceeds the healthy maximum of 3. It has increased from 10.73 (Mar 24) to 11.19, marking an increase of 0.46.
• For EV / EBITDA (X), as of Mar 25, the value is 29.58. This value exceeds the healthy maximum of 15. It has increased from 28.92 (Mar 24) to 29.58, marking an increase of 0.66.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.14. This value exceeds the healthy maximum of 3. It has increased from 10.73 (Mar 24) to 11.14, marking an increase of 0.41.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 96.91 (Mar 24) to 0.00, marking a decrease of 96.91.
• For Price / BV (X), as of Mar 25, the value is 11.70. This value exceeds the healthy maximum of 3. It has decreased from 14.67 (Mar 24) to 11.70, marking a decrease of 2.97.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.14. This value exceeds the healthy maximum of 3. It has increased from 10.73 (Mar 24) to 11.14, marking an increase of 0.41.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness